Vaccination and Alternative Immunotherapeutic Approaches against Emerging and (Re)emerging Neglected Tropical Diseases

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against (re)emerging and Tropical Infections Diseases".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 70

Special Issue Editors

Department of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA
Interests: drug and vaccine development for Chagas disease and leishmaniasis; ecology of disease; biomarkers for diagnostics; treatment follow-up
Prof. Dr. Walderez Ornelas Dutra
E-Mail Website
Guest Editor
Head of the Cell–Cell Interactions Laboratory, Department of Morphology, Federal University of Minas Gerais, Belo Horizonte, Brazil
Interests: immunoregulation of neglected tropical diseases, in particular Chagas disease, leishmaniasis and rheumatic heart disease; biomarkers of disease progression and severity and new immunotherapeutic approaches
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue aims to compile the latest advancements in the realm of innovative and enhanced vaccine formulations targeting tropical neglected pathogens. Cutting-edge immunotherapeutic approaches and mechanisms underlying the intricate host–pathogen interactions fall under the scope of this Special Issue. In addition, we encourage submissions addressing the mechanisms of action that exert influences upon the viability of the pathogens within both intermediary (invertebrate) and mammalian (comprising animal models and humans) hosts. Contributions encompassing clinical trial investigations are also invited.

Prof. Dr. Rosa A. Maldonado
Prof. Dr. Walderez Ornelas Dutra
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • antiviral vaccines
  • antiparasitic vaccines
  • antibacterial vaccines
  • immunotherapy of infectious diseases
  • adjuvants
  • immunological mechanisms
  • immunopathogenesis, innate and adaptive responses

Published Papers

This special issue is now open for submission.
Back to TopTop